[{"Assets_0_Q2_USD":132954000.0,"CommonStockSharesOutstanding_0_Q2_shares":40754681.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52437000.0,"NetIncomeLoss_1_Q2_USD":-27787000.0,"NetIncomeLoss_2_Q2_USD":-55706000.0,"StockholdersEquity_0_Q2_USD":-13255000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":4612000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":8583000.0,"Ticker":"MCRB","CIK":"1609809","name":"SERES THERAPEUTICS, INC.","OfficialName":"Seres Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"533683334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]